PCEC provides expert consulting and operational support to ensure successful adoption and meaningful clinical impact with the LucerumCarto platform
Unlocking precision in brain health
transforming personalized medicine
LucerumCarto integrates EEG neuroanalytics with neuropsychiatric assessments and treatment outcomes to create a robust framework for understanding and treating brain disorders.
By leveraging the strengths of qEEG aligned with neuropsychiatric evaluations clinicians can achieve a higher level of diagnostic accuracy. This ensures that patients receive the most appropriate and effective treatments for neurological and psychiatric conditions and integrates research tools and data-drive neuroscience into the day-to-day clinical practice.
This integrated diagnostic approach is particularly effective in tailoring interventions to individual needs and monitoring their impacts, as well as guiding neuromodulation.
User-friendly portal built for clinicians
Secure HIPAA compliant patient database
State-of-the-art EEG analytical tools and advanced brain mapping
Connectomics
Neurotransmitter predictions
Multimodal visualization interface: qEEG, neuropsychiatric tests, symptoms, outcomes
TMS guidance and EEG-neuromodulation
Embedded statistics and AI/ML tools
Interoperability and easy retrieval of standardized data
NEUROTRANSMITTER
PREDICTIONS
Aligning functional and molecular brain-mapping
to accelerate personalized medicine
EEG-based Neurotransmitter Dominance
A Unique Approach Pioneered by PCEC
We are excited to play a pioneering role in EEG-neuroimaging applications to precision psychiatry. We have recently completed the development of a series of unique cross-species algorithms relating neurotransmitter contribution to changes in neural oscillations due to a drug or therapeutic intervention. Based on these groundbreaking innovative applications of key neuroscience and neuroimaging advances, LucerumCarto platform will empower our clinician partners to better understand the brain networks dysregulated and increase the precision of diagnostic and medication choice. We have built a seamless link between our research platform LucerumKey and our clinical platform LucerumCarto, to allow future cutting-edge applications of artificial intelligence on large data and a variety of biomarker approaches.
Collaborations with researchers and innovators
We value collaboration in research and development. We partner with innovators to build unique commercial applications harnessing the power of platform-based EEG neuroimaging and neurotransmitter predictions. Partner with us for AI-enabled custom neuroimaging research.